Budesonide-formoterol (inhalation powder) in the treatment of COPD.

about

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

P2860

Q35747036-D4D702ED-B9C1-4EA5-8E2A-8A99A4EC2198

P2860

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

Item

http://www.wikidata.org/entity/Q37018887

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

@en

Budesonide-formoterol

@nl

type

Item

label

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

@en

Budesonide-formoterol

@nl

prefLabel

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

@en

Budesonide-formoterol

@nl

P1476

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

@en

P2093

Erkan Ceylan

http://www.w3.org/2001/XMLSchema#string

P2860

Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.

Inhaled budesonide/formoterol combination.

Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data.

Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.

Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid.

Pharmacological factors that influence the choice of inhaled corticosteroids.

Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

P304

115-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/COPD.2006.1.2.115

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5800817

http://www.w3.org/2001/XMLSchema#string

P698

18046888

http://www.w3.org/2001/XMLSchema#string

P921

Chidenhi

Alcoal

amine

chronic obstructive pulmonary disease

polycyclic compound

P932

2706613

http://www.w3.org/2001/XMLSchema#string

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

about

P2860

P2860

Budesonide-formoterol (inhalation powder) in the treatment of COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932